Загрузка...
Clinical Use of Pharmacogenomic Tests in 2009
Pharmacogenomics is a new field where testing an individual can define either a risk status for an adverse event, or the rate of metabolism of a drug. This is achieved by the categorisation of the enzyme activity or documenting genetic polymorphisms of a metabolising enzyme. The best example of risk...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
The Australian Association of Clinical Biochemists
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2702214/ https://ncbi.nlm.nih.gov/pubmed/19565025 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|